198 related articles for article (PubMed ID: 24254220)
21. Effects of cannabinoid (CBD) on blood brain barrier permeability after brain injury in rats.
Jiang H; Li H; Cao Y; Zhang R; Zhou L; Zhou Y; Zeng X; Wu J; Wu D; Wu D; Guo X; Li X; Wu H; Li P
Brain Res; 2021 Oct; 1768():147586. PubMed ID: 34289379
[TBL] [Abstract][Full Text] [Related]
22. Effect of acute poly(ADP-ribose) polymerase inhibition by 3-AB on blood-brain barrier permeability and edema formation after focal traumatic brain injury in rats.
Lescot T; Fulla-Oller L; Palmier B; Po C; Beziaud T; Puybasset L; Plotkine M; Gillet B; Meric P; Marchand-Leroux C
J Neurotrauma; 2010 Jun; 27(6):1069-79. PubMed ID: 20380552
[TBL] [Abstract][Full Text] [Related]
23. TNFα alters occludin and cerebral endothelial permeability: Role of p38MAPK.
Ni Y; Teng T; Li R; Simonyi A; Sun GY; Lee JC
PLoS One; 2017; 12(2):e0170346. PubMed ID: 28170408
[TBL] [Abstract][Full Text] [Related]
24. Biochanin A Protects Against Lipopolysaccharide-Induced Damage of Dopaminergic Neurons Both In Vivo and In Vitro via Inhibition of Microglial Activation.
Wang J; Wu WY; Huang H; Li WZ; Chen HQ; Yin YY
Neurotox Res; 2016 Oct; 30(3):486-98. PubMed ID: 27417698
[TBL] [Abstract][Full Text] [Related]
25. Somatostatin ameliorates lipopolysaccharide-induced tight junction damage via the ERK-MAPK pathway in Caco2 cells.
Lei S; Cheng T; Guo Y; Li C; Zhang W; Zhi F
Eur J Cell Biol; 2014 Jul; 93(7):299-307. PubMed ID: 24950815
[TBL] [Abstract][Full Text] [Related]
26. Microglial Activation Damages Dopaminergic Neurons through MMP-2/-9-Mediated Increase of Blood-Brain Barrier Permeability in a Parkinson's Disease Mouse Model.
Ruan Z; Zhang D; Huang R; Sun W; Hou L; Zhao J; Wang Q
Int J Mol Sci; 2022 Mar; 23(5):. PubMed ID: 35269933
[TBL] [Abstract][Full Text] [Related]
27. Inhibition of prothrombin kringle-2-induced inflammation by minocycline protects dopaminergic neurons in the substantia nigra in vivo.
Nam JH; Leem E; Jeon MT; Kim YJ; Jung UJ; Choi MS; Maeng S; Jin BK; Kim SR
Neuroreport; 2014 May; 25(7):489-95. PubMed ID: 24488033
[TBL] [Abstract][Full Text] [Related]
28. Role of p38 and inducible nitric oxide synthase in the in vivo dopaminergic cells' degeneration induced by inflammatory processes after lipopolysaccharide injection.
Ruano D; Revilla E; Gavilán MP; Vizuete ML; Pintado C; Vitorica J; Castaño A
Neuroscience; 2006 Jul; 140(4):1157-68. PubMed ID: 16713109
[TBL] [Abstract][Full Text] [Related]
29. Licochalcone A Prevents the Loss of Dopaminergic Neurons by Inhibiting Microglial Activation in Lipopolysaccharide (LPS)-Induced Parkinson's Disease Models.
Huang B; Liu J; Ju C; Yang D; Chen G; Xu S; Zeng Y; Yan X; Wang W; Liu D; Fu S
Int J Mol Sci; 2017 Sep; 18(10):. PubMed ID: 28937602
[TBL] [Abstract][Full Text] [Related]
30. Lipopolysaccharide downregulates the expression of ZO-1 protein through the Akt pathway.
Zou P; Yang F; Ding Y; Zhang D; Liu Y; Zhang J; Wu D; Wang Y
BMC Infect Dis; 2022 Oct; 22(1):774. PubMed ID: 36199030
[TBL] [Abstract][Full Text] [Related]
31. Naloxone protects rat dopaminergic neurons against inflammatory damage through inhibition of microglia activation and superoxide generation.
Liu B; Du L; Hong JS
J Pharmacol Exp Ther; 2000 May; 293(2):607-17. PubMed ID: 10773035
[TBL] [Abstract][Full Text] [Related]
32. Tenuigenin protects dopaminergic neurons from inflammation-mediated damage induced by the lipopolysaccharide.
Yuan HL; Li B; Xu J; Wang Y; He Y; Zheng Y; Wang XM
CNS Neurosci Ther; 2012 Jul; 18(7):584-90. PubMed ID: 22759267
[TBL] [Abstract][Full Text] [Related]
33. Inhibition of poly (adenosine diphosphate-ribose) polymerase attenuates lung-kidney crosstalk induced by intratracheal lipopolysaccharide instillation in rats.
Si MK; Mitaka C; Tulafu M; Abe S; Kitagawa M; Ikeda S; Eishi Y; Kurata S; Tomita M
Respir Res; 2013 Nov; 14(1):126. PubMed ID: 24229378
[TBL] [Abstract][Full Text] [Related]
34. Protective effect of rhEPO on tight junctions of cerebral microvascular endothelial cells early following traumatic brain injury in rats.
Zhiyuan Q; Qingyong L; Shengming H; Hui M
Brain Inj; 2016; 30(4):462-7. PubMed ID: 26934476
[TBL] [Abstract][Full Text] [Related]
35. An In Vitro Model of the Blood-Brain Barrier: Naegleria fowleri Affects the Tight Junction Proteins and Activates the Microvascular Endothelial Cells.
Coronado-Velázquez D; Betanzos A; Serrano-Luna J; Shibayama M
J Eukaryot Microbiol; 2018 Nov; 65(6):804-819. PubMed ID: 29655298
[TBL] [Abstract][Full Text] [Related]
36. Protection against dopaminergic neurodegeneration in Parkinson's disease-model animals by a modulator of the oxidized form of DJ-1, a wild-type of familial Parkinson's disease-linked PARK7.
Inden M; Kitamura Y; Takahashi K; Takata K; Ito N; Niwa R; Funayama R; Nishimura K; Taniguchi T; Honda T; Taira T; Ariga H
J Pharmacol Sci; 2011; 117(3):189-203. PubMed ID: 22041943
[TBL] [Abstract][Full Text] [Related]
37. Cordycepin attenuates traumatic brain injury-induced impairments of blood-brain barrier integrity in rats.
Yuan J; Wang A; He Y; Si Z; Xu S; Zhang S; Wang K; Wang D; Liu Y
Brain Res Bull; 2016 Oct; 127():171-176. PubMed ID: 27646481
[TBL] [Abstract][Full Text] [Related]
38. DL-3-n-butylphthalide protects the blood-brain barrier against ischemia/hypoxia injury via upregulation of tight junction proteins.
Ye ZY; Xing HY; Wang B; Liu M; Lv PY
Chin Med J (Engl); 2019 Jun; 132(11):1344-1353. PubMed ID: 30939485
[TBL] [Abstract][Full Text] [Related]
39. PARP inhibition attenuates early brain injury through NF-κB/MMP-9 pathway in a rat model of subarachnoid hemorrhage.
Chen T; Wang W; Li JR; Xu HZ; Peng YC; Fan LF; Yan F; Gu C; Wang L; Chen G
Brain Res; 2016 Aug; 1644():32-8. PubMed ID: 27157545
[TBL] [Abstract][Full Text] [Related]
40. The Neuroprotective Role of Insulin Against MPP(+) -Induced Parkinson's Disease in Differentiated SH-SY5Y Cells.
Ramalingam M; Kim SJ
J Cell Biochem; 2016 Apr; 117(4):917-26. PubMed ID: 26364587
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
